| Bahrain | | |
Tuberculosis incidence (per 100,000 population) | 15.0 (2021) [136/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.0 (2020) [174/194countries] | | | Reported number of people requiring interventions against NTDs | 3 (2021) [42/83countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 16.1 (2019) [123/183countries] | | |
|
| Bahrain | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 112.2 (2020) [147/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 6.2 (2020) [64/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 3.2 (2020) [81/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 44.2 (2020) [96/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 3.9 (2020) [174/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 8.6 (2020) [114/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 5.9 (2020) [106/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.6 (2020) [100/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.8 (2020) [121/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.3 (2020) [103/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 5.1 (2020) [94/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.6 (2020) [118/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 3.7 (2020) [145/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 11.7 (2020) [96/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 1.0 (2020) [175/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.2 (2020) [99/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.6 (2020) [58/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 7.7 (2020) [69/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 1.7 (2020) [119/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.1 (2020) [160/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 8.2 (2020) [42/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 3.5 (2020) [100/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 13.3 (2020) [152/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 4.8 (2020) [114/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.5 (2020) [129/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 2.4 (2020) [124/184countries] | | |
|
| Bahrain | | |
Suicide, age-standardized (per 100 000 population) | 7.20 (2019) [113/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 9.86 (2019) [121/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 2.27 (2019) [135/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 8.61 (2019) [50/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 13.06 (2019) [51/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 2.70 (2019) [88/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 13.21 (2019) [40/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 16.32 (2019) [57/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 5.12 (2019) [47/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 12.10 (2019) [61/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 16.02 (2019) [87/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 2.69 (2019) [129/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 8.50 (2019) [119/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 12.32 (2019) [125/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 1.21 (2019) [169/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 5.41 (2019) [150/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 8.19 (2019) [149/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 1.21 (2019) [165/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 5.32 (2019) [158/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 7.70 (2019) [161/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 2.15 (2019) [157/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 11.76 (2019) [124/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 17.40 (2019) [132/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 6.61 (2019) [108/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 30.11 (2019) [89/183countries] | | |
|
|